Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

IntegenX Announces ISO 9001:2008 Certification

Published: Friday, April 04, 2014
Last Updated: Tuesday, April 15, 2014
Bookmark and Share
Company awarded the ISO 9001:2008 certification for the design, development, manufacture, and distribution of automated DNA identification systems.

IntegenX Inc. announce that it has earned ISO 9001:2008 certification for its quality management system for the design, development, manufacture and distribution of automated DNA identification systems. IntegenX manufactures the RapidHIT® System for human identification and is the first company in the rapid DNA market to achieve such a standard.

“Meeting a high quality standard is a priority for everyone at IntegenX,” said David V. Smith, Chief Operating Officer. “Fulfilling the stringent requirements of the ISO 9001:2008 standard is part of our effort to deliver total customer satisfaction as it relates to quality.”

ISO 9001:2008 is a quality management system standard developed by the International Organization for Standardization, an association of governmental and nongovernmental organizations from 163 countries that develops international standards. The ISO 9001:2008 standard is used to certify quality management systems that focus on customer satisfaction, continuous improvement, active involvement of senior management and employees, and the adoption of a process approach. Certification under ISO 9001:2008 implies customers will benefit from products that are robust and reliable, readily available meeting international regulatory standards.

“Earning certification is a significant accomplishment by our employees’, reflecting their commitment and hard work,” commented Robert A. Schueren, President, Chief Executive Officer. “Our customers expect exceptional products that also adhere to the highest standards of quality and performance.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

First State-Wide deployment of the RapidHIT® System
IntegenX Inc. announced the first state-wide deployment of the RapidHIT System for real-time matching of DNA profiles.
Sunday, May 18, 2014
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!